Skip to main content

Table 2 List of the clinical trials conducted in Vietnam to date a

From: Current challenges and possible solutions to improve access to care and treatment for hepatitis C infection in Vietnam: a systematic review

Year Title City Sponsor Status
2010–2016 Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection Ho Chi Minh City, Hai Phong University of Hawaii Active, not recruiting
2014–2016 The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment’s Effects on Chronic Hepatitis C Patients Unknown Nanogen Pharmaceutical Biotechnology Co., Ltd Completed
2015–2016 Feasibility of Interventions on People Who Inject Drugs in Vietnam    
Implementation of a Sexual Health Intervention for Young Men Who Have Sex With Men (MSM) in Two Vietnamese Cities Ho Chi Minh City, Hanoi Inserm-ANRS Completed
2013–2016 HCV Treatment in HIV Co-Infected Patients in Asia Hanoi amfAR, Completed
2016 Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients Unknown Debiopharm International SA Completed, has results
2011–2016 Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants Unknown Debiopharm International SA Completed, has results
2016–2017 Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV Unknown Gilead Sciences Recruiting
2015 3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study   Novartis Pharmaceuticals Completed
2014–2016 Implementation of a Sexual Health Intervention for Young Men Who Have Sex With Men (MSM) in Two Vietnamese Cities Hanoi National Development and Research Institutes, Inc. Completed
  1. aFor further details please see the following website: ClinicalTrials.gov